News
TMPTF
0.300
NaN%
--
TempraMed Signs Exclusive Distribution Agreement with SPORTORO for Croatia, Serbia and Bosnia and Herzegovina
Newsfile · 4d ago
TempraMed Enters into Exclusive Kuwait Distribution Agreement, Expanding Gulf Region Commercial Footprint
Newsfile · 10/15 07:05
TempraMed Granted Mexican Patent for Newest Product, VIVI Box
Newsfile · 10/08 07:05
TempraMed Announces VIVI Cap Smart Connectivity with Apple Health and Google Fit, Providing Better Health Outcomes and Data Tracking
Newsfile · 10/05 07:05
TempraMed Technologies Ltd. Announces Closing of Private Placement
Newsfile · 09/30 22:00
TempraMed Signs Letter of Intent with CPO Cyprus for Exclusive Distribution of VIVI Products in Cyprus
Newsfile · 09/29 07:05
TempraMed upsizes private placement to C$1.6M
Seeking Alpha · 09/28 21:57
TempraMed Announces Upsize to Offering
Newsfile · 09/28 21:49
TempraMed expands LATAM distribution deal and announces C$1M financing
Seeking Alpha · 09/24 07:52
TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement
Newsfile · 09/24 06:55
TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana
Newsfile · 09/23 07:05
TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already Exceeding Full-Year 2025 Revenue
Newsfile · 09/18 20:45
TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece
Newsfile · 09/01 10:45
TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap
Newsfile · 08/25 11:00
TempraMed Announces Extension of Maccabi Healthcare Services Agreement
Newsfile · 08/20 11:00
TempraMed Executes Definitive Exclusive Distribution Agreement with TEM in Panama, Advancing Commercial Expansion Across Clinics and Pharmacies
Newsfile · 08/18 11:00
TempraMed Announces Strategic Partnership with Stealth Health, a Leading Telemedicine Platform for Longevity and Wellness
Newsfile · 08/04 11:00
TempraMed Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
Newsfile · 07/30 11:00
TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million Lives
Newsfile · 07/09 11:00
TempraMed Signs LOI for Exclusive Distribution in Kuwait, Expanding Presence in High-Growth Gulf Region Healthcare Market
Newsfile · 07/06 11:00
More
Webull provides a variety of real-time TMPTF stock news. You can receive the latest news about TempraMed Tech through multiple platforms. This information may help you make smarter investment decisions.
About TMPTF
TempraMed Technologies Ltd. is a Canada-based company. The Company is engaged in providing temperature-controlled medication storage solutions. It develops patented, FDA-registered, space-grade thermal insulation devices that work 24/7 for years without charging or external power. These devices operate continuously without the need for charging or external power sources. Its product line includes VIVI Cap and VIVI Epi, and the Company is developing a technology platform intended to support the management of temperature-sensitive medications. The Company has operations in North America, Europe, and Asia.